findmyKOL
Clinical trialNCT03283761CompletedPhase 2Interventional

FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

SponsorAl B. Benson, III, MDEnrollment39Gastric CancerGastro-Esophageal Junction Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an open label, single-arm phase II, multi-institutional trial to evaluate the efficacy and safety of the combination of nab-paclitaxel and FOLFOX (FOLFOX-A) as first line therapy for patients diagnosed with histologically-confirmed advanced gastric/GEJ adenocarcinoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, United States

  • Univeristy of Illinois Cancer Center

    Chicago, Illinois, United States

  • Northwestern Medicine Lake Forest Hospital

    Lake Forest, Illinois, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • Michigan State University

    Lansing, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, United States

  • University of Wisconsin

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fluorouracil →Leucovorin →Paclitaxel →Oxaliplatin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Sept 2017
Primary completion
27 Dec 2022
Completion
16 Jan 2023
Last update posted
6 Feb 2024
Registered enrollment
39
Registry id
NCT03283761
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.